Sioux Falls Clinic Introduces New FDA-Approved Treatment for Keratoconus
Sioux Falls is now offering Epioxa, a new FDA-approved treatment for keratoconus, a progressive eye condition that causes blurred vision. Vance Thompson Vision is the first practice in South Dakota to provide this advanced "epithelium-on" corneal cross-linking procedure, which aims…
Sioux Falls, SD, November 4, 2026 — Sioux Falls, SD – A new treatment option for keratoconus, a progressive eye condition characterized by blurred vision, is now available in Sioux Falls. Vance Thompson Vision has become the first practice in South Dakota to offer Epioxa, a recently FDA-approved treatment.
Keratoconus affects the cornea, the clear front surface of the eye, causing it to thin and develop an irregular, cone-like shape. This distortion leads to blurred and distorted vision, and in some cases, can significantly impact quality of life.
Epioxa is described as an advanced “epithelium-on” corneal cross-linking procedure. This therapeutic approach aims to strengthen the cornea. By increasing the rigidity of the corneal tissue, the procedure is intended to slow the progression of keratoconus. The goal of such treatments is to stabilize the condition and prevent further deterioration of vision.
Vance Thompson Vision stated that this new procedure may also offer benefits related to patient experience, potentially reducing discomfort and recovery time compared to some existing methods. The FDA approval signifies that the treatment has met rigorous standards for safety and effectiveness.
The availability of Epioxa in Sioux Falls provides local patients diagnosed with keratoconus with access to a novel treatment option without needing to travel outside the state for this specific procedure. Further details on patient eligibility and the procedure itself would typically be discussed with a healthcare provider specializing in ophthalmology.
Story summarized from the original created by Jodi Schwan on siouxfalls.business, see more information here.
